vs
Side-by-side financial comparison of BingEx Ltd (FLX) and Prenetics Global Ltd (PRE). Click either name above to swap in a different company.
BingEx Ltd is the larger business by last-quarter revenue ($143.2M vs $92.0M, roughly 1.6× Prenetics Global Ltd).
Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.
FLX vs PRE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $143.2M | $92.0M |
| Net Profit | $3.2M | — |
| Gross Margin | 10.8% | 39.2% |
| Operating Margin | — | — |
| Net Margin | 2.2% | — |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $143.2M | — | ||
| Q3 25 | $141.2M | — | ||
| Q2 25 | $143.0M | — | ||
| Q1 25 | $141.0M | — | ||
| Q3 24 | $164.6M | — | ||
| Q1 23 | — | $92.0M | ||
| Q3 22 | — | $74.7M | ||
| Q1 22 | — | $57.5M |
| Q1 26 | $3.2M | — | ||
| Q3 25 | $6.1M | — | ||
| Q2 25 | $7.5M | — | ||
| Q1 25 | $27.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q1 26 | 10.8% | — | ||
| Q3 25 | 11.1% | — | ||
| Q2 25 | 12.0% | — | ||
| Q1 25 | 10.0% | — | ||
| Q3 24 | 11.3% | — | ||
| Q1 23 | — | 39.2% | ||
| Q3 22 | — | 34.5% | ||
| Q1 22 | — | 38.2% |
| Q1 26 | — | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 4.0% | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | -7.2% | ||
| Q1 22 | — | — |
| Q1 26 | 2.2% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | 19.6% | — | ||
| Q3 24 | 2.1% | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $561.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | $1.3B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $561.1M | — | ||
| Q3 25 | $628.6M | — | ||
| Q2 25 | $499.4M | — | ||
| Q1 25 | $592.4M | — | ||
| Q3 24 | $517.4M | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q1 26 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q3 24 | $926.8M | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
